Micro-choice-based Intervention for Multicausal Fatigue
Recruiting now · Not applicable
Conditions studied: Multicausal Fatigue, Fatigue, Post COVID Condition, Long COVID Syndrome, Postviral Fatigue
In brief
This proof-of-concept study aims to evaluate the feasibility, acceptability, and potential benefits of a novel multimodal approach: the micro-choice-based intervention.
Key facts
- Study ID
- NCT07726082
- Run by
- University Hospital, Basel, Switzerland
- People needed
- 24
- Starts
- 2026-08-01
- Expected to finish
- 2027-08-01
- Last updated by the study team
- 2026-08-06
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Experiencing persistent fatigue with a significant impact on daily functioning (Chalder Fatigue- Scale bimodal ≥ 4)
You may not qualify if…
- Have insufficient proficiency in German to complete study-related questionnaires
- Lack the cognitive capacity to understand study procedures (e.g. due to dementia)
- Present with severe medical conditions that may interfere with participation (e.g., advanced organ failure, uncontrolled inflammatory or autoimmune diseases, or severe psychiatric disorders)
- Have active cancer or are currently undergoing cancer treatment
- Are deemed incompatible with group participation during the preparation phase, based on a team assessment. Reasons for exclusion based on group incompatibility include:
- Need for a level of individual therapeutic support that exceeds what can be provided in a group setting; b) Refusal to engage in group-based therapy; c) Personality traits that are considered incompatible with group dynamics; d) Failure to attend the mandatory preparatory webinar (no-show is considered a no-go); e) Other significant reasons as determined by the therapeutic team)
Where it is running
- University Hospital Basel — Basel, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.